MedTrace Logo

Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry

NCT05704517 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-03-21

No results posted yet for this study

Summary

The project will amalgamate data from several large Indian centers to describe the genotype, clinical spectrum, natural course, genotype-phenotype correlation, outcome, and response to medical therapy in Indian children with progressive familial intrahepatic cholestasis (PFIC). This will be the first such Indian registry of children with PFIC. There are currently limited single-center studies describing the genotype, natural course, and outcome of Indian children with PFIC.

Data will be collected retrospectively from the participating centers across the country. Only genetically confirmed cases would be included.

Conditions

  • Progressive Familial Intrahepatic Cholestasis

Sponsors & Collaborators

  • Apollo Hospital, New Delhi, India

    collaborator OTHER

  • Sahyadri Superspeciality Hospital Pvt Ltd, Pune

    collaborator UNKNOWN

  • Glenegales Global Health City, Chennai

    collaborator UNKNOWN

  • KEM Hospital Research Centre

    collaborator OTHER

  • Jaslok Hospital and Research Centre

    collaborator OTHER

  • Institute of Child Health, Chennai

    collaborator UNKNOWN

  • Institute of Liver and Biliary Sciences, India

    lead OTHER

Principal Investigators

  • Bikrant B Lal, MD, DM · Institute of Liver and Biliary Sciences, New Delhi

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-28
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704517 on ClinicalTrials.gov